Created at Source Raw Value Validated value
Feb. 4, 2023, 8 p.m. usa

[{"arm_notes": "nan", "treatment_id": null, "treatment_name": "ChAdOx1-S not less than 2.5 \u00d7 10^8 infectious units", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "ChAdOx1-S not less than 2.5 \u00d7 10^8 infectious units", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "GBP510 adjuvanted with AS03 (Receptor-Binding Domain(RBD) 25ug/dose)", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "GBP510 adjuvanted with AS03 (Receptor-Binding Domain(RBD) 25ug/dose)", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "GBP510 adjuvanted with AS03 (Receptor-Binding Domain(RBD) 25ug/dose)", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "GBP510 adjuvanted with AS03 (Receptor-Binding Domain(RBD) 25ug/dose)", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}]

[{"arm_notes": "control cohort 1", "treatment_id": 161, "treatment_name": "Chadox1 ncov-19", "treatment_type": "Non replicating viral vector", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "control cohort 2", "treatment_id": 161, "treatment_name": "Chadox1 ncov-19", "treatment_type": "Non replicating viral vector", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "control cohort 3", "treatment_id": 161, "treatment_name": "Chadox1 ncov-19", "treatment_type": "Non replicating viral vector", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "cohort 1", "treatment_id": 1524, "treatment_name": "As03 adjuvant+gbp510", "treatment_type": "Adjuvant+protein subunit", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "cohort 2", "treatment_id": 1524, "treatment_name": "As03 adjuvant+gbp510", "treatment_type": "Adjuvant+protein subunit", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "cohort 3", "treatment_id": 1524, "treatment_name": "As03 adjuvant+gbp510", "treatment_type": "Adjuvant+protein subunit", "pharmacological_treatment": "Vaccine"}]

Aug. 17, 2021, 6 p.m. usa

[{"arm_notes": "nan", "treatment_id": null, "treatment_name": "ChAdOx1-S not less than 2.5 \u00d7 10^8 infectious units", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "ChAdOx1-S not less than 2.5 \u00d7 10^8 infectious units", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "GBP510 adjuvanted with AS03 (Receptor-Binding Domain(RBD) 25ug/dose)", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "GBP510 adjuvanted with AS03 (Receptor-Binding Domain(RBD) 25ug/dose)", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}]

[{"arm_notes": "", "treatment_id": 1524, "treatment_name": "As03 adjuvant+gbp510", "treatment_type": "Adjuvant+protein subunit", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "", "treatment_id": 161, "treatment_name": "Chadox1 ncov-19", "treatment_type": "Non replicating viral vector", "pharmacological_treatment": "Vaccine"}]